101
Participants
Start Date
November 21, 2021
Primary Completion Date
December 7, 2023
Study Completion Date
December 7, 2023
Ropivacaine 0.1% Injectable Solution
DPE
Bupivacaine 0.25% Injectable Solution
CSE
Duke University Hospital, Durham
Lead Sponsor
Duke University
OTHER